Sohini Das

CII President R Mukundan says cutting approval and project timelines can lower capital costs, while stable policies are essential to sustaining private investment and growth

Domestic PV dispatches rose 36.5 per cent to 439,309 units, while exports declined to 68,230 units as automakers built supplies ahead of the festive season

Luxury car makers Merc, BMW say localisation would not be hit by FTA

European carmakers get a first-year quota of 100,000 ICE and hybrid cars, while Indian-origin vehicles priced up to 50,000 euros get access to a 250,000-unit EU quota

Rs 1,000-cr IPO opens September 16

Tesseract targeted to quickly scale to 10,000 units a month; EV maker sees scooters and motorcycles contributing equally at scale, exports rising to 25% of volumes

Monthly performance translates into annualised transaction GMV run-rate of around Rs 11,000 crore; adjusted net revenue run-rate crosses Rs 2,000 crore

Rural India accounts for 55% of 2W registrations, but EV penetration is nearly half that in cities

VinFast climbs to 4th, Hyundai's registrations more than double

The company expects the decentralised model to at least double its annual testing volume to around 6,000 from the current 3,000

Anode materials will corner the largest share of investment as the company targets 60,000-tonne capacity by FY32

Sahyadri acquisition lifts FY26 revenue 25%, but higher debt, depreciation and taxes pull PAT down 15%; ARPOB rises 9%

The drugmaker has more than ₹500 crore of capital available and is evaluating businesses that can add differentiated chemistry, regulatory access and export capabilities

Promoter family buys 0.57% stake from TPG-backed Centella, two months after Aster-Quality Care merger became effective

Nexon enters market as Osprey, becoming Tata's fifth PV offering; India already supplies over half of South Africa's light-vehicle imports

TML CV Holdings will offer €14.10 per Iveco share, with the initial acceptance period running from September 7 to October 26 and payment scheduled for October 30

Bengaluru company expects annual volumes to double as decentralised test lowers logistical barriers to personalised treatment

Kaisha Pharma will manufacture ampoules, vials, prefilled syringes and cartridges, while targeting Indian and global pharmaceutical and biotechnology companies

Domestic dispatches rise 20-43% across major CV makers; M&HCVs lead growth as industry heads into festive period with stronger demand momentum

First electric Range Rover kicks off crucial new-product cycle after British luxury arm weighed on Tata Motors PV earnings amid falling revenue and margins